Month: March 2022

Live Conference Call and Webcast at 5:30 p.m. ET FORT COLLINS, Colo., March 28, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (Nasdaq: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company will host a conference call and live audio webcast on Thursday, March 31, 2022, at 5:30 p.m. ET, to discuss its corporate and financial results for the fourth quarter and full year ended December 31, 2021. Conference Call & Webcast DetailsDate Thursday, March 31, 2022Time 5:30 p.m. ETLive Audio Webcast https://edge.media-server.com/mmc/p/yffrdzzpTelephone Access: U.S. and Canada 800-937-6813Telephone Access: International 213-660-0853Access Code for All Callers 5398016A...

An Additional Layer of Protection Against Thermal Runaway While Maintaining High Energy DensityEnovix BrakeFlow Illustration BrakeFlow, shown here in green, provides an additional layer of protection against thermal runaway while maintaining high energy densityFREMONT, Calif., March 28, 2022 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced its latest advancement called BrakeFlow™ technology, an intra-cell system that significantly increases tolerance against thermal runaway from internal shorts, without compromising high energy density. “When we founded Enovix in 2007, our approach to improving cell performance was unique from other advanced battery technology companies,” said Harrold Rust, Co-Founder,...

Press Release March 28, 2022 Signify completes share repurchase program to cover performance share plans Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has completed its previously announced share repurchase program. The company repurchased a total of 850,000 shares for a total consideration of EUR 35.5 million from February 24 to March 25, 2022. These repurchases were made as part of the company’s repurchase program, which was announced on February 24, 2022. Signify will use the shares to cover obligations arising from its long-term incentive performance share plans and other employee share plans. In the period March 21 to March 25, 2022, the company repurchased 195,704 shares at an average price of EUR 43.15 per share and an aggregate amount of EUR 8.4m. Details on the share...

PHILADELPHIA, March 28, 2022 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that management will participate in the following upcoming virtual investor conferences: Guggenheim 3rd Annual Genomic Medicines & Rare Disease Day Format: Fireside ChatDate: Thursday, March 31, 2022Time: 9:00 a.m. ET 21st Annual Needham Virtual Healthcare ConferenceFormat: PresentationDate: Wednesday, April 13, 2022Time: 2:15 p.m. ET Chardan Genetic Medicines and Cell Therapy Manufacturing Summit Format: PresentationDate: Tuesday, April 26, 2022Time: 11:30 a.m. ET A live webcast of these events will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com....

NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today that Prospect’s preferred stock offerings (collectively, the “Preferred Stock”) have reached approximately $600 million in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020. “Prospect’s preferred stock offers investors recurring cash income with a stable stated value, ongoing liquidity, management alignment, leverage caps, and over $4 billion of junior common equity credit support,” said Grier Eliasek, President of Prospect. “Each of the institutional, registered investment advisors, wirehouse, independent private wealth, and international investor channels have invested in Prospect’s preferred stock.” Preferred...